Table 3 Secondary SUN AC grading outcomes.

From: A double-blind, randomized controlled pilot study comparing the safety of intracameral levofloxacin and intracameral cefazolin in patients undergoing cataract surgery

Variable

Levofloxacin (0.1 ml/0.5 mg)

n = 25

Cefazolin (0.1 ml/1 mg)

n = 25

P value

AC flare, n (%)

0 (None)

1 (Faint)

24 (96)

1 (4)

24 (96)

1 (4)

1.00

AC cell at Week 1, n (%)

0 (< 1)

0.5 (1–5)

1 (6–15)

2 (8)

20 (80)

3 (12)

0

22 (88)

3 (12)

0.50

AC cell at Month 1, n (%)

0 (< 1)

0.5 (1–5)

1 (6–15)

23 (92)

1 (4)

1 (4)

23 (92)

1 (4)

1 (4)

1.00

AC cell at Month 3, n (%)

0 (< 1)

0.5 (1–5)

1 (6–15)

23 (92)

1 (4)

1 (4)

24 (96)

0

1 (4)

0.57

  1. AC = anterior chamber; SUN = Standardization of Uveitis Nomenclature.